High Court's Stanford Ruling Puts Special Demands on Life Sciences, Attorneys Say
June 17, 2011
Attorneys and life sciences companies expressed concern that, as a result of the Supreme Court's June 6 ruling that the Bayh-Dole Act does not bar inventors from assigning their individual rights in patents resulting from federally funded research, a research organization's efforts to properly secure rights to that invention will become more complicated and more demands will be placed on life sciences research than on other areas.
Reproduced with permission from Life Sciences Law & Industry Report, 5 LSLR 597 (June 17, 2011). Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.